Resources
Home
/
Resources
-
Current Role of MS in Cell Line Development of Biotherapeutics
Speaker Presentation Technical Seminar Presented by Thermo Fisher Scientific 2024 -
Characterization of Complex cIEF Electropherograms from mAb and Antibody-Drug Conjugate (ADC) Using a Novel icIEF-UV/MS System
Speaker Presentation Technical Seminar Presented by SCIEX 2024
-
New Technologies for Rapid Characterization of Biologics: From R&D to Manufacturing
Speaker Presentation Technical Seminar Presented by Refeyn Inc. 2024
-
Automating Cell-Based Assays: Reducing Variability & Time to Results
Speaker Presentation Technical Seminar Presented by Catalent Pharma Solutions 2024
-
Potency Assays for ATMPs – Selection of Assay Platforms and Data Processing Methods are Key Aspects for Successful Control Strategies
Speaker Presentation Technical Seminar Presented by BioAgilytix Labs, LLC 2024
-
Untangling the Complexity within Oligonucleotide Therapeutics
Speaker Presentation Technical Seminar Presented by Agilent Technologies 2024
-
Microchip CE-MS for Rapid, Deep and Sensitive Analysis of Biopharmaceuticals
Speaker Presentation Technical Seminar Presented by 908 Devices 2024
-
Experiences with Implementing ICH Q12 ECs and PLCM
Speaker Presentation Stangler Thomas Sandoz GmbH 2024
-
The Visual Inspection Regulatory and Compendial Environment: Current Issues and Opportunities
Speaker Presentation Shabushnig John G. Insight Pharma Consulting, LLC 2024
-
Accelerating Biopharmaceutical Development: Data-Driven Strategies, Platforms, and Technologies
Speaker Presentation Rathore Nitin Amgen Inc. 2024
-
Drug Delivery Innovations for CEPI’s 100 Days Mission
Speaker Presentation Patel Dimki CEPI 2024
-
An Industry Perspective on the Use of Forced Degradation Studies to Assess Comparability of Biopharmaceuticals
Speaker Presentation Nowinski Ann (Kasia) Pfizer, Inc. 2024
-
From Blur to Clarity: Definition of Particle VisibilityThreshold in Parenteral Drug Products
Speaker Presentation Nikels Felix Boehringer Ingelheim Pharma GmbH & Co. KG and Koulov Atanas Clear Solutions Laboratories 2024
-
A Journey Through the Biopharmaceutical Industry
Speaker Presentation Miller Ken BioMarin Pharmaceutical Inc. 2024
-
Building a Comparability Strategy for a Major Post-Approval Manufacturing Change
Speaker Presentation McKnight Nathan Genentech, a Member of the Roche Group 2024
-
Considerations for Animal Use and Sustainability
– A Regulatory Perspective
Speaker Presentation Levis Robin CBER, FDA 2024
-
Intro to Bayesian and Frequentist Statistics
Speaker Presentation Kirk Jennifer CBER, FDA 2024
-
Could ADCs be the Drug Equivalent of Lego®?
Speaker Presentation Ihle Nathan Bolt Biotherapeutics and Krantz Carol Pfizer Inc. 2024
-
Platform Analytical Procedures – Applying Concepts in ICH Q2(R2) and ICH Q14
Speaker Presentation Finkler Christof F. Hoffman-La Roche Ltd. and Viswanathan Balaji Pfizer, Inc. 2024
-
Designing and Manufacturing Medicines with Sustainability at the Core
Speaker Presentation Dell'orco Philip GlaxoSmithKline 2024